Retracted: Meta-analysis of Randomized Trials of Ivermectin to Treat SARS-CoV-2 Infection

Ivermectin is an antiparasitic drug being investigated for repurposing against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Ivermectin showed in vitro activity against SARS-COV-2, but only at high concentrations. This meta-analysis investigated ivermectin in 23 randomized clinical t...

Descripción completa

Detalles Bibliográficos
Autores principales: Hill, Andrew, Garratt, Anna, Levi, Jacob, Falconer, Jonathan, Ellis, Leah, McCann, Kaitlyn, Pilkington, Victoria, Qavi, Ambar, Wang, Junzheng, Wentzel, Hannah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8420640/
https://www.ncbi.nlm.nih.gov/pubmed/34796244
http://dx.doi.org/10.1093/ofid/ofab358

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8420640/
https://www.ncbi.nlm.nih.gov/pubmed/34796244
http://dx.doi.org/10.1093/ofid/ofab358

Ejemplares similares